91É«ÇéƬ
Back to
Dr Nicki Meagher

Dr Nicki Meagher

Lecturer

BMedSci, MPH, PhD

Medicine & Health
School of Population Health

Ìý

Dr Nicki Meagher is a Cancer Institute NSW Early Career Research Fellow and a Scientia Lecturer in the School of Population Health, 91É«ÇéƬ. Dr Meagher is an expert in ovarian cancer epidemiology, and her workÌýuses large datasets and epidemiological techniques to answer questions that can change practice and improve outcomes for people with ovarian cancer.

She has broad expertise in molecular epidemiology and biomarker-based research as well as working with administrative health data to address areas of clinical need in ovarian cancer.
E-mail
nicki.meagher@unsw.edu.au
Location
School of Population Health Level 5, Health Translation Hub (C29) 91É«ÇéƬ Sydney NSW 2052
  • Book Chapters | 2010
    Smee RI; Wiliams J; Schneider M; Meagher N, 2010, 'Non-Surgical Management of Meningiomas Involving the Cavernous Sinus: Radiosurgery', in Radiosurgery, Basal Karger, pp. 189 - 201,
  • Journal articles | 2026
    De Boeck A; Kang EY; Meagher NS; Gorringe KL; Lee CH; Minoo P; Köbel M, 2026, 'A 5-marker immunohistochemical panel of CK17, MEP1A, PAX8, SMAD4, and CDX2 to distinguish ovarian mucinous carcinoma from metastatic pancreatic ductal adenocarcinoma', Histopathology, 88, pp. 402 - 413,
    Journal articles | 2026
    Zwimpfer TA; Fereday S; Pandey A; Ariyaratne D; Jayawardana MW; Twomey L; Laumont CM; Kennedy CJ; Bolithon A; Meagher NS; Milne K; Hamilton P; Alsop J; Antoniou AC; Au-Yeung G; Beckmann MW; Berrington de Gonzalez A; Bisinotto C; Blome F; Bodelon C; Boros J; Brand AH; Carney ME; Cazorla-Jiménez A; Chiu DS; Christie EL; Chudecka-Głaz A; Coulson P; Cushing-Haugen KL; Cybulski C; Darcy KM; David C; Davidson T; Ekici AB; Elishaev E; Emons J; Engler T; Farrell R; Fischer A; García-Closas M; Gentry-Maharaj A; Ghatage P; Glasspool R; Harter P; Hartkopf AD; Hartmann A; Heikaus S; Hernandez BY; Hettiaratchi A; Heublein S; Huntsman DG; Jimenez-Linan M; Jones ME; Kang E; Kaznowska E; Kluz T; Kommoss FKF; Konecny G; Kruitwagen RFPM; Kwon J; Lambrechts D; Lee C-H; Lester J; Leung SCY; Leung Y; Linder A; Lissowska J; Loverix L; Lubiński J; Mateoiu C; McNeish IA; Moubarak M; Nelson GS; Nevins N; Olawaiye AB; Olbrecht S; Orsulic S; Osorio A; Quinn CM; Mohan GR; Ray-Coquard I; Rodríguez-Antona C; Roxburgh P; Ruebner M; Salfinger SG; Samra S; Schoemaker MJ; Sinn H-P; Sonke GS; Steele L; Stewart CJR; Talhouk A; Tan A; Tarney CM; Taylor SE; Van de Vijver KK; van der Aa MA; Van Gorp T; Van Nieuwenhuysen E; Van-Wagensveld L; Wahner-Hendrickson AE; Walter C; Wang C; Welz J; Wentzensen N; Wilkens LR; Winham SJ; Winterhoff B; Anglesio MS; Berchuck A; Candido Dos Reis FJ; Cohen PA; Conrads TP; Crowe P; Doherty JA; Fasching PA; Fortner RT; García MJ; Gayther SA; Goodman MT; Gronwald J; Harris HR; Heitz F; Horlings HM; Karlan BY; Kelemen LE; Larry Maxwell G; Menon U; Modugno F; Neuhausen SL; Schildkraut JM; Staebler A; Sundfeldt K; Swerdlow AJ; Vergote I; Wu AH; Brenton JD; Pharoah PDP; Pearce CL; Pike MC; Goode EL; Ramus SJ; Köbel M; Nelson BH; DeFazio A; Friedlander ML; Bowtell DDL; Garsed DW, 2026, 'Clinicopathologic and molecular predictors of survival in BRCA-deficient tubo-ovarian high-grade serous carcinoma.', Nat Commun,
    Journal articles | 2025
    Fu Z; Borho L; Taylor SE; Kelemen LE; DeFazio A; Webb PM; Köbel M; Meagher NS; Na R; Antoniou AC; Brand AH; Kennedy CJ; Nevins N; Pharoah PDP; Shvetsov YB; Winham SJ; Alsop J; Beckmann MW; Bolithon A; Boros J; Bowtell DDL; Brenton JD; Carney ME; Chudecka-Głaz A; Cook LS; Cybulski C; Fasching PA; Fereday S; Fortner RT; García MJ; Goode EL; Goodman MT; Gronwald J; Hartmann A; Hernandez BY; Høgdall E; Huntsman DG; Jensen A; Jimenez-Linan M; Joseph JM; Karlan BY; Kaznowska E; Kjaer SK; Kluz T; Koziak JM; Lester J; Longacre TA; Lycke M; McGuire V; Moysich KB; Murphy RA; Orsulic S; Ramus SJ; Rodríguez-Antona C; Rothstein JH; Samra S; Sieh W; Steed H; Sundfeldt K; Talhouk A; Uciński J; Wang C; Wentzensen N; Whittemore AS; Wilkens LR; Songer T; Brooks MM; Tang L; Modugno F, 2025, 'Ovarian cancer risk and survival according to tumor sex hormone receptor expression: An ovarian Cancer association consortium and ovarian tumor tissue analysis consortium pooled analysis', Gynecologic Oncology, 198, pp. 112 - 129,
    Journal articles | 2025
    Goldsbury DE; Kang YJ; Tang C; Tanha HM; Smit AK; Dunlop KLA; Petelin L; Ngo P; Hui H; Meagher NS; Merritt MA; Weber M; DeFazio A; Cust AE; Canfell K; Steinberg J, 2025, 'Sociodemographic and health factors associated with genetic testing in Australia: insights from a cohort-based study of 45,061 participants', European Journal of Human Genetics, 33, pp. 819 - 824,
    Journal articles | 2025
    Meagher NS; Köbel M; Karnezis AN; Talhouk A; Anglesio MS; Berchuck A; Gayther SA; Pharoah PPD; Webb PM; Ramus SJ; Gorringe KL, 2025, 'Cellular origins of mucinous ovarian carcinoma', Journal of Pathology, 266, pp. 9 - 25,
    Journal articles | 2024
    Köbel M; Kang EY; Lee S; Terzic T; Karnezis AN; Ghatage P; Woo L; Lee CH; Meagher NS; Ramus SJ; Gorringe KL, 2024, 'Infiltrative pattern of invasion is independently associated with shorter survival and desmoplastic stroma markers FAP and THBS2 in mucinous ovarian carcinoma', Histopathology, 84, pp. 1095 - 1110,
    Journal articles | 2024
    Meagher NS; Hathaway C; Townsend MK; Barnard ME; Conejo-Garcia JR; Fridley BL; Saeed-Vafa D; Trabert B; Tworoger SS; Merritt MA, 2024, 'Abstract A089: Influence of pre-diagnosis aspirin use on epithelial ovarian cancer tumor immune microenvironment markers: results from the Nurses’ Health Study (NHS) and NHSII', Cancer Research, 84, pp. A089 - A089,
    Journal articles | 2024
    Meagher NS; White KK; Wilkens LR; Bandera EV; Berchuck A; Carney ME; Cramer DW; Cushing-Haugen KL; Jordan S; Kaufmann SH; Le ND; Pike MC; Riggan M; Qin B; Rothstein JH; Titus L; Winham SJ; Anton-Culver H; Doherty JA; Goode EL; Pearce CL; Risch HA; Webb PM; Cook LS; Goodman MT; Harris HR; Le Marchand L; McGuire V; Pharoah PDP; Sarink D; Schildkraut JM; Sieh W; Terry KL; Thompson PJ; Whittemore AS; Wu AH; Peres LC; Merritt MA, 2024, 'Racial and ethnic differences in epithelial ovarian cancer risk: an analysis from the Ovarian Cancer Association Consortium', American Journal of Epidemiology, 193, pp. 1242 - 1252,
    Journal articles | 2024
    Meagher NS; White KK; Wilkens LR; Webb PM; Wu AH; Peres LC; Merritt MA, 2024, 'Abstract B113: Associations between risk factors and epithelial ovarian cancer survival by racial and ethnic group: an analysis from the ovarian cancer association consortium', Cancer Research, 84, pp. B113 - B113,
    Journal articles | 2024
    Nelson BH; Hamilton P; Phung MT; Milne K; Harris B; Thornton S; Stevens D; Kalaria S; Singh K; Laumont CM; Moss E; Alimujiang A; Meagher NS; Bolithon A; Fereday S; Kennedy CJ; Hendley J; Ariyaratne D; Alsop K; Traficante N; Goode EL; Karnezis A; Shen H; Richardson J; McKinnonDeurloo C; Chase A; Grout B; Doherty JA; Harris HR; Cushing-Haugen KL; Anglesio M; Heinze K; Huntsman D; Talhouk A; Hanley GE; Alsop J; Jimenez-Linan M; Pharoah PDP; Boros J; Brand AH; Harnett PR; Sharma R; Hecht JL; Sasamoto N; Terry KL; Karlan B; Lester J; Carney ME; Goodman MT; Hernandez BY; Wilkens LR; Behrens S; Fortner RT; Fasching PA; Bisinotto C; dos Reis FJC; Ghatage P; Köbel M; Elishaev E; Modugno F; Cook L; Le N; Gentry-Maharaj A; Menon U; García MJ; Rodriguez-Antona C; Farrington K; Kelemen LE; Kommoss S; Staebler A; Garsed DW; Brenton JD; Piskorz AM; Bowtell DDL; DeFazio A; Ramus SJ; Pike MC; Pearce CL, 2024, 'Immunological and molecular features of the tumor microenvironment of long-term survivors of ovarian cancer', Journal of Clinical Investigation, 134,
    Journal articles | 2024
    Saner FAM; Takahashi K; Budden T; Pandey A; Ariyaratne D; Zwimpfer TA; Meagher NS; Fereday S; Twomey L; Pishas KI; Hoang T; Bolithon A; Traficante N; Alsop K; Christie EL; Kang EY; Nelson GS; Ghatage P; Lee CH; Riggan MJ; Alsop J; Beckmann MW; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; El-Bahrawy MA; Elishaev E; Erber R; Gayther SA; Gentry-Maharaj A; Blake Gilks C; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; Hernandez BY; Jakubowska A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Kluz T; Koziak JM; Kristjansdottir B; Le ND; Lener M; Lester J; Lubiński J; Mateoiu C; Orsulic S; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Rinda Soong T; Steed H; Sukumvanich P; Talhouk A; Taylor SE; Vierkant RA; Wang C; Widschwendter M; Wilkens LR; Winham SJ; Anglesio MS; Berchuck A; Brenton JD; Campbell I; Cook LS; Doherty JA; Fasching PA; Fortner RT; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sundfeldt K; Swerdlow AJ; Goode EL; DeFazio A; Köbel M; Ramus SJ; Bowtell DDL; Garsed DW, 2024, 'Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma', Clinical Cancer Research, 30, pp. 3481 - 3498,
    Journal articles | 2023
    Kang EY; Weir A; Meagher NS; Farrington K; Nelson GS; Ghatage P; Lee CH; Riggan MJ; Bolithon A; Popovic G; Leung B; Tang K; Lambie N; Millstein J; Alsop J; Anglesio MS; Ataseven B; Barlow E; Beckmann MW; Berger J; Bisinotto C; Bösmüller H; Boros J; Brand AH; Brooks-Wilson A; Brucker SY; Carney ME; Casablanca Y; Cazorla-Jiménez A; Cohen PA; Conrads TP; Cook LS; Coulson P; Courtney-Brooks M; Cramer DW; Crowe P; Cunningham JM; Cybulski C; Darcy KM; El-Bahrawy MA; Elishaev E; Erber R; Farrell R; Fereday S; Fischer A; García MJ; Gayther SA; Gentry-Maharaj A; Gilks CB; Grube M; Harnett PR; Harrington SP; Harter P; Hartmann A; Hecht JL; Heikaus S; Hein A; Heitz F; Hendley J; Hernandez BY; Polo SH; Heublein S; Hirasawa A; Høgdall E; Høgdall CK; Horlings HM; Huntsman DG; Huzarski T; Jewell A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Khabele D; Kommoss FKF; Kruitwagen RFPM; Lambrechts D; Le ND; Lener M; Lester J; Leung Y; Linder A; Loverix L; Lubiński J; Madan R; Maxwell GL; Modugno F; Neuhausen SL; Olawaiye A; Olbrecht S; Orsulic S; Palacios J; Pearce CL; Pike MC; Quinn CM; Mohan GR; Rodríguez-Antona C; Ruebner M; Ryan A; Salfinger SG, 2023, 'CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study', Cancer, 129, pp. 697 - 713,
    Journal articles | 2023
    Köbel M; Kang EY; Weir A; Rambau PF; Lee CH; Nelson GS; Ghatage P; Meagher NS; Riggan MJ; Alsop J; Anglesio MS; Beckmann MW; Bisinotto C; Boisen M; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; Deen S; El-Bahrawy MA; Elishaev E; Erber R; Fereday S; Fischer A; Gayther SA; Barquin-Garcia A; Gentry-Maharaj A; Gilks CB; Gronwald H; Grube M; Harnett PR; Harris HR; Hartkopf AD; Hartmann A; Hein A; Hendley J; Hernandez BY; Huang Y; Jakubowska A; Jimenez-Linan M; Jones ME; Kennedy CJ; Kluz T; Koziak JM; Lesnock J; Lester J; Lubiński J; Longacre TA; Lycke M; Mateoiu C; McCauley BM; McGuire V; Ney B; Olawaiye A; Orsulic S; Osorio A; Paz-Ares L; Ramón y Cajal T; Rothstein JH; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Singh N; Steed H; Storr SJ; Talhouk A; Traficante N; Wang C; Whittemore AS; Widschwendter M; Wilkens LR; Winham SJ; Benitez J; Berchuck A; Bowtell DD; Candido dos Reis FJ; Campbell I; Cook LS; DeFazio A; Doherty JA; Fasching PA; Fortner RT; García MJ; Goodman MT; Goode EL; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Kommoss S; Le ND; Martin SG; Menon U, 2023, 'p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study', Journal of Pathology Clinical Research, 9, pp. 208 - 222,
    Journal articles | 2023
    Meagher NS; Hamilton P; Milne K; Thornton S; Harris B; Weir A; Alsop J; Bisinoto C; Brenton JD; Brooks-Wilson A; Chiu DS; Cushing-Haugen KL; Fereday S; Garsed DW; Gayther SA; Gentry-Maharaj A; Gilks B; Jimenez-Linan M; Kennedy CJ; Le ND; Piskorz AM; Riggan MJ; Shah M; Singh N; Talhouk A; Widschwendter M; Bowtell DDL; Candido dos Reis FJ; Cook LS; Fortner RT; García MJ; Harris HR; Huntsman DG; Karnezis AN; Köbel M; Menon U; Pharoah PDP; Doherty JA; Anglesio MS; Pike MC; Pearce CL; Friedlander ML; DeFazio A; Nelson BH; Ramus SJ, 2023, 'Profiling the immune landscape in mucinous ovarian carcinoma', Gynecologic Oncology, 168, pp. 23 - 31,
    Journal articles | 2023
    O’Mahony DG; Ramus SJ; Southey MC; Meagher NS; Hadjisavvas A; John EM; Hamann U; Imyanitov EN; Andrulis IL; Sharma P; Daly MB; Hake CR; Weitzel JN; Jakubowska A; Godwin AK; Arason A; Bane A; Simard J; Soucy P; Caligo MA; Mai PL; Claes KBM; Teixeira MR; Chung WK; Lazaro C; Hulick PJ; Toland AE; Pedersen IS; Mourits MJE; Neuhausen SL; Vega A; de la Hoya M; Nevanlinna H; Dhawan M; Zampiga V; Danesi R; Varesco L; Gismondi V; Vellone VG; James PA; Janavicius R; Nikitina-Zake L; Nielsen FC; van Overeem Hansen T; Pejovic T; Borg A; Rantala J; Offit K; Montagna M; Nathanson KL; Domchek SM; Osorio A; García MJ; Karlan BY; Lesueur F; De Fazio A; Bowtell D; McGuffog L; Leslie G; Parsons MT; Dörk T; Speith LM; dos Santos ES; da Costa AABA; Radice P; Peterlongo P; Papi L; Engel C; Hahnen E; Schmutzler RK; Wappenschmidt B; Easton DF; Tischkowitz M; Singer CF; Tan YY; Whittemore AS; Sieh W; Brenton JD; Yannoukakos D; Fostira F; Konstantopoulou I; Soukupova J; Vocka M; Chenevix-Trench G; Pharoah PDP; Antoniou AC; Goldgar DE; Spurdle AB; Michailidou K, 2023, 'Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2', British Journal of Cancer, 128, pp. 2283 - 2294,
    Journal articles | 2023
    Saner FAM; Takahashi K; Budden T; Pandey A; Ariyaratne D; Zwimpfer TA; Meagher NS; Fereday S; Twomey L; Pishas KI; Hoang T; Bolithon A; Traficante N; Alsop K; Christie EL; Kang E-Y; Nelson GS; Ghatage P; Lee C-H; Riggan MJ; Alsop J; Beckmann MW; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; El-Bahrawy MA; Elishaev E; Erber R; Gayther SA; Gentry-Maharaj A; Blake Gilks C; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; AOCS Group ; Hernandez BY; Jakubowska A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Kluz T; Koziak JM; Kristjansdottir B; Le ND; Lener M; Lester J; Lubiński J; Mateoiu C; Orsulic S; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Singh N; Rinda Soong T; Steed H; Sukumvanich P; Talhouk A; Taylor SE; Vierkant RA; Wang C; Widschwendter M; Wilkens LR; Winham SJ; Anglesio MS; Berchuck A; Brenton JD; Campbell I; Cook LS; Doherty JA; Fasching PA; Fortner RT; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sundfeldt K; Swerdlow AJ; Goode EL; DeFazio A; Köbel M; Ramus SJ; Bowtell DDL; Garsed DW, 2023, 'Concurrent RB1 loss and BRCA-deficiency predicts enhanced immunological response and long-term survival in tubo-ovarian high-grade serous carcinoma.', medRxiv,
    Journal articles | 2023
    Weir A; Kang EY; Meagher NS; Nelson GS; Ghatage P; Lee CH; Riggan MJ; Gentry-Maharaj A; Ryan A; Singh N; Widschwendter M; Alsop J; Anglesio MS; Beckmann MW; Berger J; Bisinotto C; Boros J; Brand AH; Brenton JD; Brooks-Wilson A; Carney ME; Cunningham JM; Cushing-Haugen KL; Cybulski C; Elishaev E; Erber R; Fereday S; Fischer A; Paz-Ares L; Gayarre J; Gilks BC; Grube M; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; Hernandez BY; Heublein S; Huang Y; Huzarski T; Jakubowska A; Jimenez-Linan M; Kennedy CJ; Kommoss FKF; Koziak JM; Kraemer B; Le ND; Lesnock J; Lester J; Lubiński J; Menkiszak J; Ney B; Olawaiye A; Orsulic S; Osorio A; Robles-Díaz L; Ruebner M; Shah M; Sharma R; Shvetsov YB; Steed H; Talhouk A; Taylor SE; Traficante N; Vierkant RA; Wang C; Wilkens LR; Winham SJ; Benitez J; Berchuck A; Bowtell DDL; Candido dos Reis FJ; Cook LS; DeFazio A; Doherty JA; Fasching PA; García MJ; Goode EL; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kommoss S; Modugno F; Schildkraut JM; Sinn HP; Staebler A; Kelemen LE; Ford CE; Menon U; Pharoah PDP; Köbel M; Ramus SJ, 2023, 'Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium Study', British Journal of Cancer, 128, pp. 137 - 147,
    Journal articles | 2022
    Kang EY; Millstein J; Popovic G; Meagher NS; Bolithon A; Talhouk A; Chiu DS; Anglesio MS; Leung B; Tang K; Lambie N; Pavanello M; Da-anoy A; Lambrechts D; Loverix L; Olbrecht S; Bisinotto C; Garcia-Donas J; Ruiz-Llorente S; Yagüe-Fernandez M; Edwards RP; Elishaev E; Olawaiye A; Taylor S; Ataseven B; du Bois A; Harter P; Lester J; Høgdall CK; Armasu SM; Huang Y; Vierkant RA; Wang C; Winham SJ; Heublein S; Kommoss FKF; Cramer DW; Sasamoto N; van-Wagensveld L; Lycke M; Mateoiu C; Joseph J; Pike MC; Odunsi K; Tseng CC; Pearce CL; Bilic S; Conrads TP; Hartmann A; Hein A; Jones ME; Leung Y; Beckmann MW; Ruebner M; Schoemaker MJ; Terry KL; El-Bahrawy MA; Coulson P; Etter JL; LaVigne-Mager K; Andress J; Grube M; Fischer A; Neudeck N; Robertson G; Farrell R; Barlow E; Quinn C; Hettiaratchi A; Casablanca Y; Erber R; Stewart CJR; Tan A; Yu Y; Boros J; Brand AH; Harnett PR; Kennedy CJ; Nevins N; Morgan T; Fasching PA; Vergote I; Swerdlow AJ; Candido dos Reis FJ; Maxwell GL; Neuhausen SL; Barquin-Garcia A; Modugno F; Moysich KB; Crowe PJ; Hirasawa A; Heitz F; Karlan BY; Goode EL; Sinn P; Horlings HM; Høgdall E; Sundfeldt K; Kommoss S; Staebler A, 2022, 'MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma', Virchows Archiv, 480, pp. 855 - 871,
    Journal articles | 2022
    Meagher NS; Gorringe KL; Wakefield M; Bolithon A; Pang CNI; Chiu DS; Anglesio MS; Mallitt KA; Doherty JA; Harris HR; Schildkraut JM; Berchuck A; Cushing-Haugen KL; Chezar K; Chou A; Tan A; Alsop J; Barlow E; Beckmann MW; Boros J; Bowtell DDL; Brand AH; Brenton JD; Campbell I; Cheasley D; Cohen J; Cybulski C; Elishaev E; Erber R; Farrell R; Fischer A; Fu Z; Gilks B; Gill AJ; Gourley C; Grube M; Harnett PR; Hartmann A; Hettiaratchi A; Høgdall CK; Huzarski T; Jakubowska A; Jimenez-Linan M; Kennedy CJ; Kim BG; Kim JW; Kim JH; Klett K; Koziak JM; Lai T; Laslavic A; Lester J; Leung Y; Li N; Liauw W; Lim BWX; Linder A; Lubinski J; Mahale S; Mateoiu C; McInerny S; Menkiszak J; Minoo P; Mittelstadt S; Morris D; Orsulic S; Park SY; Pearce CL; Pearson JV; Pike MC; Quinn CM; Mohan GR; Rao J; Riggan MJ; Ruebner M; Salfinger S; Scott CL; Shah M; Steed H; Stewart CJR; Subramanian D; Sung S; Tang K; Timpson P; Ward RL; Wiedenhoefer R; Thorne H; Cohen PA; Crowe P; Fasching PA; Gronwald J; Hawkins NJ; Høgdall E; Huntsman DG; James PA; Karlan BY; Kelemen LE; Kommoss S; Konecny GE; Modugno F, 2022, 'Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes', Clinical Cancer Research, 28, pp. 5383 - 5395,
    Journal articles | 2022
    2022, 'Multi-modal immune profiling of mucinous ovarian carcinoma: analysis from the Ovarian Tumor Tissue Analysis/Multidisciplinary Ovarian Cancer Outcomes Group consortia', JOURNAL OF IMMUNOLOGY, 208,
    Journal articles | 2021
    Kang EY; Cheasley D; LePage C; Wakefield MJ; da Cunha Torres M; Rowley S; Salazar C; Xing Z; Allan P; Bowtell DDL; Mes-Masson AM; Provencher DM; Rahimi K; Kelemen LE; Fasching PA; Doherty JA; Goodman MT; Goode EL; Deen S; Pharoah PDP; Brenton JD; Sieh W; Mateoiu C; Sundfeldt K; Cook LS; Le ND; Anglesio MS; Gilks CB; Huntsman DG; Kennedy CJ; Traficante N; Chenevix-Trench G; Green A; Webb P; De Fazio A; Gertig D; Traficante N; Fereday S; Moore S; Hung J; Harrap K; Sadkowsky T; Pandeya N; Malt M; Mellon A; Robertson R; Bergh TV; Jones M; Mackenzie P; Maidens J; Nattress K; Chiew YE; Stenlake A; Sullivan H; Alexander B; Ashover P; Brown S; Corrish T; Green L; Jackman L; Ferguson K; Martin K; Martyn A; Ranieri B; White J; Jayde V; Mamers P; Bowes L; Galletta L; Giles D; Hendley J; Alsop K; Schmidt T; Shirley H; Ball C; Young C; Viduka S; Tran H; Bilic S; Glavinas L; Brooks J; Stuart-Harris R; Kirsten F; Rutovitz J; Clingan P; Glasgow A; Proietto A; Braye S; Otton G; Shannon J; Bonaventura T; Stewart J; Begbie S; Friedlander M; Bell D; Baron-Hay S; Ferrier A; Gard G; Nevell D; Pavlakis N, 2021, 'Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses', Modern Pathology, 34, pp. 194 - 206,
    Journal articles | 2021
    Quinn CM; Porwal M; Meagher NS; Hettiaratchi A; Power C; Jonnaggadala J; McCullough S; Macmillan S; Tang K; Liauw W; Goldstein D; Zeps N; Crowe PJ; Jonnagaddala J, 2021, 'Moving with the Times: The Health Science Alliance (HSA) Biobank, Pathway to Sustainability', Biomarker Insights, 16, pp. 1 - 10,
    Journal articles | 2021
    Xu X; Wang Y; Bryce NS; Tang K; Meagher NS; Kang EY; Kelemen LE; Köbel M; Ramus SJ; Friedlander M; Ford CE; Hardeman EC; Gunning PW, 2021, 'Targeting the actin/tropomyosin cytoskeleton in epithelial ovarian cancer reveals multiple mechanisms of synergy with anti-microtubule agents', British Journal of Cancer, 125, pp. 265 - 276,
    Journal articles | 2019
    Meagher NS; Wang L; Rambau PF; Intermaggio MP; Huntsman DG; Wilkens LR; El-Bahrawy MA; Ness RB; Odunsi K; Steed H; Herpel E; Anglesio MS; Zhang B; Lambie N; Swerdlow AJ; Lubiński J; Vierkant RA; Goode EL; Menon U; Toloczko-Grabarek A; Oszurek O; Bilic S; Talhouk A; García-Closas M; Wang Q; Tan A; Farrell R; Kennedy CJ; Jimenez-Linan M; Sundfeldt K; Etter JL; Menkiszak J; Goodman MT; Klonowski P; Leung Y; Winham SJ; Moysich KB; Behrens S; Kluz T; Edwards RP; Gronwald J; Modugno F; Hernandez BY; Chow C; Kelemen LE; Keeney GL; Carney ME; Natanzon Y; Robertson G; Sharma R; Gayther SA; Alsop J; Luk H; Karpinskyj C; Campbell I; Sinn P; Gentry-Maharaj A; Coulson P; Chang-Claude J; Shah M; Widschwendter M; Tang K; Schoemaker MJ; Koziak JM; Cook LS; Brenton JD; Daley F; Kristjansdottir B; Mateoiu C; Larson MC; Harnett PR; Jung A; deFazio A; Gorringe KL; Pharoah PDP; Minoo P; Stewart C; Bathe OF; Gui X; Cohen P; Ramus SJ; Köbel M, 2019, 'A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases', Modern Pathology, 32, pp. 1834 - 1846,
    Journal articles | 2018
    Meagher NS; Schuster K; Voss A; Budden T; Pang CNI; deFazio A; Ramus SJ; Friedlander ML, 2018, 'Does the primary site really matter? Profiling mucinous ovarian cancers of uncertain primary origin (MO-CUP) to personalise treatment and inform the design of clinical trials', Gynecologic Oncology, 150, pp. 527 - 533,
    Journal articles | 2016
    Na R; Laaksonen MA; Grulich AE; Meagher NS; McCaughan GW; Keogh AM; Vajdic CM, 2016, 'High azathioprine dose and lip cancer risk in liver, heart, and lung transplant recipients: A population-based cohort study Presented orally at the 42nd Annual Scientific Meeting of the Clinical Oncology Society of Australia in Hobart, Australia on November 17, 2015.', Journal of the American Academy of Dermatology, 74, pp. 1144 - 1152.e6,
    Journal articles | 2016
    Na R; Laaksonen MA; Grulich AE; Meagher NS; McCaughan GW; Keogh AM; Vajdic CM, 2016, 'Iatrogenic immunosuppression and risk of non-Hodgkin lymphoma in solid organ transplantation: A population-based cohort study in Australia', British Journal of Haematology, 174, pp. 550 - 562,
    Journal articles | 2015
    Na R; Laaksonen MA; Grulich AE; Webster AC; Meagher NS; Mccaughan GW; Keogh AM; Vajdic CM, 2015, 'Longitudinal dose and type of immunosuppression in a national cohort of Australian liver, heart, and lung transplant recipients, 1984-2006', Clinical Transplantation, 29, pp. 978 - 990,
    Journal articles | 2015
    Swart A; Meagher NS; Van Leeuwen MT; Zhao K; Grulich A; Mao L; Randall DA; Degenhardt L; Burns L; O'Connell D; Amin J; Vajdic CM, 2015, 'Examining the quality of name code record linkage: What is the impact on death and cancer risk estimates? A validation study', Australian and New Zealand Journal of Public Health, 39, pp. 141 - 147,
    Journal articles | 2015
    Vajdic CM; Marashi Pour S; Olivier J; Swart A; O'Connell DL; Falster MO; Meagher NS; Mao L; Grulich AE; Randall DA; Amin J; Burns L; Degenhardt L, 2015, 'Corrigendum to "The impact of blood-borne viruses on cause-specific mortality among opioid dependent people: An Australian population-based cohort study" [Drug Alcohol Depend. 152C (2015) 264-271] DOI: 10.1016/j.drugalcdep.2015.03.026', Drug and Alcohol Dependence, 154, pp. 304,
    Journal articles | 2015
    Vajdic CM; Pour SM; Olivier J; Swart A; O'Connell DL; Falster MO; Meagher NS; Mao L; Grulich AE; Randall DA; Amin J; Burns L; Degenhardt L, 2015, 'The impact of blood-borne viruses on cause-specific mortality among opioid dependent people: An Australian population-based cohort study', Drug and Alcohol Dependence, 152, pp. 264 - 271,
    Journal articles | 2014
    Koegelenberg AM; Dean S; Meagher NS; Caruso L; Goode S; Pillai U; Marsh DJ; Brown S; Walczak A; Yip S; Kench JG; Horvath L; Nielsen S; Hawkins NJ; Scott R, 2014, 'CLOSING THE GAP BETWEEN RESEARCH, BIOBANKS AND CLINICAL PRACTICE: A 12 MONTH EXPLORATORY STUDY INTO DEVELOPING A STANDARD PRE-OPERATIVE MODEL FOR OBTAINING BIOBANK CONSENT', ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 10, pp. 35 - 35,
    Journal articles | 2014
    Meagher NS; Dean S; Koegelenberg A; Goode S; Caruso L; Pillai U; Marsh DJ; Brown S; Yip S; Walczak A; Kench JG; Horvath L; Nielsen S; Scott R; Hawkins NJ, 2014, 'INTEGRATING UNIVERSAL CONSENT FOR BIOBANKING AND HEALTH DATA COLLECTION WITHIN CLINICAL PATHWAYS IN NSW - THE BSN CONSENT PROJECT', ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 10, pp. 22 - 23,
    Journal articles | 2014
    Vajdic CM; Chong AH; Kelly PJ; Meagher NS; Van Leeuwen MT; Grulich AE; Webster AC, 2014, 'Survival after cutaneous melanoma in kidney transplant recipients: A population-based matched cohort study', American Journal of Transplantation, 14, pp. 1368 - 1375,
    Journal articles | 2014
    Vajdic CM; Er CC; Schaffer A; Dobbins T; Wyld L; Meagher NS; Barrett J; Ward RL; Pearson SA, 2014, 'An audit of cancer of unknown primary notifications: A cautionary tale for population health research using cancer registry data', Cancer Epidemiology, 38, pp. 460 - 464,
    Journal articles | 2014
    Van Leeuwen MT; Turner JJ; Joske DJ; Falster MO; Srasuebkul P; Meagher NS; Grulich AE; Giles GG; Vajdic CM, 2014, 'Lymphoid neoplasm incidence by WHO subtype in Australia 1982-2006', International Journal of Cancer, 135, pp. 2146 - 2156,
    Journal articles | 2013
    Na R; Grulich AE; Meagher N; Mccaughan GW; Keogh AM; Vajdic CM, 2013, 'De novo cancer-related death in Australian liver and cardiothoracic transplant recipients', American Journal of Transplantation, 13, pp. 1296 - 1304,
    Journal articles | 2013
    Na R; Grulich AE; Meagher NS; McCaughan GW; Keogh AM; Vajdic CM, 2013, 'Comparison of de novo cancer incidence in Australian liver, heart and lung transplant recipients', Am J Transplant, 13, pp. 174 - 183,
    Journal articles | 2013
    Van Leeuwen MT; Turner J; Falster M; Meagher N; Joske D; Grulich AE; Giles GG; Vajdic CM, 2013, 'Latitude gradients for lymphoid neoplasm subtypes in Australia support an association with ultraviolet radiation exposure', International Journal of Cancer, 133, pp. 944 - 951,
    Journal articles | 2012
    Smee RI; Williams JR; D K; Meagher N; Cohn R, 2012, 'Medulloblastoma: Progress over time', Journal of Medical Imaging and Radiation Oncology, 56, pp. 227 - 234
    Journal articles | 2012
    Swart AM; Burns LA; Mao L; Grulich AE; Amin J; O Connell DL; Meagher N; Randall D; Degenhardt LJ; Vajdic CM; O'Connell D, 2012, 'The importance of blood-borne viruses in elevated cancer risk among opioid-dependent people: a population-based cohort study', BMJ Open, 2, pp. e001755 - e001755,
    Journal articles | 2012
    Vajdic CM; Meagher N; Hicks S; Faedo M; Ward RL; Pearson S, 2012, 'Governance approval for multisite, non-interventional research: What can Harmonisation of Multi-Centre Ethical Review learn from the New South Wales experience?', Internal Medicine Journal, 42, pp. 127 - 131,
    Journal articles | 2011
    Smee RI; Broadley K; Williams JR; Meagher N; Bridger P, 2011, 'Retained Role of Surgery for Olfactory Neuroblastoma', Head and Neck, 33, pp. 1486 - 1492,
    Journal articles | 2010
    Smee RI; Meagher N; Williams JR; Broadley K, 2010, 'The Role of Radiotherapy for Early Glottic Carcinoma', Head and Neck: Journal for the Sciences and Specialties of the Head and Neck, 32, pp. 850 - 859
    Journal articles | 2009
    Smee RI; Meagher N; Broadley K; Ho T; Williams JR; Bridger GP, 2009, 'Recurrent Nasopharyngeal Carcinoma - Current Management Approaches',
  • Working Papers | 2023
    Saner FAM; Takahashi K; Budden T; Pandey A; Ariyaratne D; Zwimpfer TA; Meagher NS; Fereday S; Twomey L; Pishas KI; Hoang T; Bolithon A; Traficante N; Alsop K; Christie EL; Kang E-Y; Nelson GS; Ghatage P; Lee C-H; Riggan MJ; Alsop J; Beckmann MW; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; El-Bahrawy MA; Elishaev E; Erber R; Gayther SA; Gentry-Maharaj A; Blake Gilks C; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; AOCS Group ; Hernandez BY; Jakubowska A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Kluz T; Koziak JM; Kristjansdottir B; Le ND; Lener M; Lester J; Lubiński J; Mateoiu C; Orsulic S; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Singh N; Rinda Soong T; Steed H; Sukumvanich P; Talhouk A; Taylor SE; Vierkant RA; Wang C; Widschwendter M; Wilkens LR; Winham SJ; Anglesio MS; Berchuck A; Brenton JD; Campbell I; Cook LS; Doherty JA; Fasching PA; Fortner RT; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sundfeldt K; Swerdlow AJ; Goode EL; DeFazio A; Köbel M; Ramus SJ; Bowtell DDL; Garsed DW, 2023, Concurrent RB1 loss and BRCA-deficiency predicts enhanced immunological response and long-term survival in tubo-ovarian high-grade serous carcinoma., ,
  • Preprints | 2025
    Zwimpfer TA; Fereday S; Pandey A; Ariyaratne D; Jayawardana MW; Twomey L; Laumont CM; Kennedy CJ; Bolithon A; Meagher NS; Milne K; Hamilton P; Alsop J; Antoniou AC; Au-Yeung G; Beckmann MW; Berrington de Gonzalez A; Bisinotto C; Blome F; Bodelon C; Boros J; Brand AH; Carney ME; Cazorla-Jiménez A; Chiu DS; Christie EL; Chudecka-Głaz A; Coulson P; Cushing-Haugen KL; Cybulski C; Darcy KM; David C; Davidson T; Ekici AB; Elishaev E; Emons J; Engler T; Farrell R; Fischer A; García-Closas M; Gentry-Maharaj A; Ghatage P; Glasspool R; Harter P; Hartkopf AD; Hartmann A; Heikaus S; Hernandez BY; Hettiaratchi A; Heublein S; Huntsman DG; Jimenez-Linan M; Jones ME; Kang E; Kaznowska E; Kluz T; Kommoss FKF; Konecny G; Kruitwagen RFPM; Kwon J; Lambrechts D; Lee C-H; Lester J; Leung SCY; Leung Y; Linder A; Lissowska J; Loverix L; Lubiński J; Mateoiu C; McNeish IA; Moubarak M; Nelson GS; Nevins N; Olawaiye AB; Olbrecht S; Orsulic S; Osorio A; Quinn CM; Mohan GR; Ray-Coquard I; Rodríguez-Antona C; Roxburgh P; Ruebner M; Salfinger SG; Samra S; Schoemaker MJ; Sinn H-P; Sonke GS; Steele L; Stewart CJR; Talhouk A; Tan A; Tarney CM; Taylor SE; Van de Vijver KK; van der Aa MA; Van Gorp T; Van Nieuwenhuysen E; van-Wagensveld L; Wahner-Hendrickson AE; Walter C; Wang C; Welz J; Wentzensen N; Wilkens LR; Winham SJ; Winterhoff B; Anglesio MS; Berchuck A; Candido Dos Reis FJ; Cohen PA; Conrads TP; Crowe P; Doherty JA; Fasching PA; Fortner RT; García MJ; Gayther SA; Goodman MT; Gronwald J; Harris HR; Heitz F; Horlings HM; Karlan BY; Kelemen LE; Maxwell GL; Menon U; Modugno F; Neuhausen SL; Schildkraut JM; Staebler A; Sundfeldt K; Swerdlow AJ; Vergote I; Wu AH; Brenton JD; Pharoah PDP; Pearce CL; Pike MC; Goode EL; Ramus SJ; Köbel M; Nelson BH; DeFazio A; Friedlander ML; Bowtell DDL; Garsed DW, 2025, Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinoma.,
    Conference Abstracts | 2022
    Meagher NS; Hamilton PT; Anglesio MS; Harris HR; Konecny GE; Schildkraut JM; Talhouk A; Friedlander ML; Pearce CL; Pike MC; Kobel M; Doherty JA; Goode EL; Nelson BH; DeFazio A; Ramus SJ, 2022, 'Multi-modal immune profiling of mucinous ovarian carcinoma: analysis from the Ovarian Tumor Tissue Analysis/Multidisciplinary Ovarian Cancer Outcomes Group consortia', in JOURNAL OF IMMUNOLOGY, AMER ASSOC IMMUNOLOGISTS, OR, Portland, Vol. 208, presented at Immunology Meeting, OR, Portland, 06 May 2022 - 10 May 2022,
    Preprints | 2021
    Heinze K; Nazeran T; Lee S; Krämer P; Cairns E; Chiu D; Leung SCY; Kang EY; Meagher N; Kennedy C; Boros J; Kommoss F; Vollert H-W; Heitze F; du Bois A; Harter P; Grube M; Kraemer B; Staebler A; Kommoss FKF; Heublein S; Sinn H-P; Singh N; Laslavic A; Elishaev E; Olawaiye A; Moysich K; Modugno F; Sharma R; Brand A; Harnett P; DeFazio A; Fortner R; Lubinski J; Lener M; Tołoczko-Grabarek A; Cybulski C; Gronwald H; Gronwald J; Coulson P; El-Bahrawy M; Jones M; Schoemaker M; Swerdlow A; Gorringe K; Campbell I; Cook L; Gayther S; Carney M; Shvetsov Y; Hernandez B; Wilkens L; Goodman M; Mateoiu C; Linder A; Sundfeldt K; Kelemen L; Gentry-Maharaj A; Widschwendter M; Menon U; Bolton K; Alsop J; Shah M; Jimenez-Linan M; Pharoah PDP; Brenton J; Cushing-Haugen K; Harris H; Doherty J; Gilks B; Ghatage P; Huntsman D; Nelson G; Tinker A; Lee C-H; Goode E; Nelson B; Ramus S; Kommoss S; Talhouk A; Köbel M; Anglesio M, 2021, Prognostic and Immunological Significance of ARID1A Status in Endometriosis-Associated Ovarian Carcinoma,
    Conference Papers | 2021
    Xu X; Wang Y; Bryce N; Tang K; Meagher NS; Kang EY; Kelemen LE; Köbel M; Ramus SJ; Friedlander M; Ford CE; Hardeman EC; Gunning PW, 2021, 'Abstract 1045: Combined targeting of actin/tropomyosin and microtubules underlies a potential treatment strategy of epithelial ovarian cancer with cell-cycle dependent synergy', in Cancer Research, American Association for Cancer Research (AACR), pp. 1045 - 1045,
    Conference Abstracts | 2017
    Meagher NS; deFazio A; Russell K; Voss A; Ramus SJ; Friedlander ML, 2017, 'Mucinous Ovarian Cancers of Uncertain Primary (MO-CUP) - Does the Site of Origin Really Matter?', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 13, pp. 73 - 73,
    Conference Papers | 2016
    Jonnagaddala J; Croucher JL; Jue TR; Meagher NS; Caruso L; Ward R; Hawkins NJ, 2016, 'Integration and Analysis of Heterogeneous Colorectal Cancer Data for Translational Research', in Nursing Informatics 2016, pp. 387 - 387
    Conference Abstracts | 2015
    Croucher JL; Jonnagaddala J; Frances M; Caruso L; Meagher NS; Hawkins NJ; Frances M, 2015, 'In the thick of it: Or how to get tranSMART about data curation', in eResearch Australasia, Brisbane, Australia,
    Conference Abstracts | 2015
    Jitendra Jonnagaddala NJH; Croucher J; Caruso L; Meagher N; Ward R; Hawkins N; Kumar M, 2015, 'Integrating biospecimen, clinical, imaging and biomarker data to support translational research: A preliminary study in colorectal cancer', in Biobanking Stakeholder Network Symposium, 22 May 2015, Sydney, Australia,
    Conference Abstracts | 2015
    Jonnagaddala J; Croucher JL; Meagher NS; Kumar M; Caruso L; Jue TR; London J; Ward RL; Hawkins NJ, 2015, 'Supporting translational research: Accessing colorectal cancer research data', in Australian Open Research Data Showcase, Canberra, Australia,
    Conference Abstracts | 2014
    Meagher NS; Scott G; Hettiaratchi A; Schwensen J; Jonnagaddala J; Caruso L; Ward RL; Crowe P; Salisbury E; Liauw W; others ; Hawkins N, 2014, 'Two years, fifteen hundred consents and counting. Integrating the HSA Biobank within routine clinical practice within the SESLHD.', in Innovations in Cancer Treatment and Care, Sydney, Australia, 17 October 2014.,
    Conference Papers | 2014
    Na R; Grulich A; Meagher N; McCaughan G; Keogh A; Laaksonen M; Vajdic C, 2014, 'Risk of Early and Late Non-Hodgkin Lymphoma (NHL) in Australian Liver and Cardiothoracic Transplant Recipients.', in AMERICAN JOURNAL OF TRANSPLANTATION, WILEY-BLACKWELL, CA, San Francisco, pp. 67 - 67, presented at World Transplant Congress, CA, San Francisco, 26 July 2014 - 31 July 2014,
    Conference Papers | 2014
    Na R; Grulich AE; Meagher NS; McCaughan GW; Keogh AM; Laaksonen M; Vajdic CM, 2014, 'RISK OF EARLY AND LATE NON-HODGKIN LYMPHOMA (NHL) IN AUSTRALIAN LIVER AND CARDIOTHORACIC TRANSPLANT RECIPIENTS', in IMMUNOLOGY AND CELL BIOLOGY, NATURE PUBLISHING GROUP, AUSTRALIA, ANU Campus, Canberra, pp. A9 - A9, presented at 32nd Annual Scientific Meeting of the Transplantation-Society-of-Australia-and-New-Zealand, AUSTRALIA, ANU Campus, Canberra, 10 June 2014 - 13 June 2014,
    Conference Presentations | 2013
    Schaffer AL; Pearson S-A; Dobbins T; Er C; Meagher NS; Barrett J; Ward RL; Vajdic CM, 2013, 'HEALTH SERVICE USE, TREATMENT PATTERNS, AND SURVIVAL FOR CANCER OF UNKNOWN PRIMARY: A DATA LINKAGE STUDY',
    Conference Abstracts | 2013
    Vajdic CM; Chong AH; Kelly PJ; Meagher NS; Van Leeuwen MT; Grulich AE; Webster AC, 2013, 'Survival after cutaneous melanoma in kidney transplant recipients: A population-based matched cohort study', in Asia Pacific Journal of Clinical Oncology, Wiley, Adelaide Convention Centre, Vol. 9, pp. 134 - 135, presented at Clinical Oncological Society of Australia 40th Annual Scientific Meeting, Adelaide Convention Centre, 12 November 2013 - 14 November 2013,
    Conference Abstracts | 2013
    Vajdic CM; Chong AH; Kelly PJ; Meagher NS; van Leeuwen MT; Grulich AE; Webster AC, 2013, 'Survival after cutaneous melanoma in kidney transplant recipients: A population-based matched cohort study.', in Cancer Research, American Association for Cancer Research, Washington, DC, Vol. 73, presented at 104th Annual Meeting of the American Association for Cancer Research (AACR), Washington, DC, 06 April 2013 - 10 April 2013,

2025-2028 Cancer Institute NSW Early Career Fellowship.

2025 Ovarian Cancer Research Alliance Mentored Investigator grant.Ìý‘Equitable access to BRCA testing: an Australian national data linkage study.’

Ìý

2025 Penny Taylor Prize for excellence in ovarian cancer research.

2024 Australia New Zealand Gynaecological Oncology Group (ANZGOG) Michael Friedlander AM award forÌýemerging early career researcher.

2024ÌýANZGOG Best Pre-clinical Poster Award.

Ìý

2025-PresentÌýÌý Ovarian Cancer Association Consortium Epidemiology Working Group

2024-PresentÌýÌý ANZGOG Equity, Diversity and Inclusion Reference Group

2024-PresentÌýÌý Co-chair, ‘Pure Science Symposium’ and ANZGOG Annual Scientific Meeting Program Steering Committee (2025 and 2026 conferences)

2023-PresentÌýÌý Chair, Health Precincts Biobank Research Access Committee, 91É«ÇéƬ (member since 2020)

2022-PresentÌýÌý ANZGOG Ovarian Tumour Type Working group